Prophylactic and therapeutic parotidectomy for secondary neoplasms of the parotid gland

Authors : Ayca ANT, Felat TOPRAK, Caner KILIÇ, Samet ÖZLÜGEDİK, Arzubetül DURAN, Tuncay TUNÇCAN

Pages : 561-568

Doi:10.18621/eurj.538156

View : 22 | Download : 9

Publication Date : 2020-11-04

Article Type : Research Paper

Abstract :Objectives: The aim of this study was to review the demographic and clinicopathological findings of the patients who underwent prophylactic or therapeutic parotidectomy due to the secondary neoplasm of the parotid gland insert ignore into journalissuearticles values(SNP);, the outcomes of the patients with SNP and to provide a perspective to the parotid and neck approach in head and neck skin cancer cases. Methods: The clinical data of 178 patients who underwent parotidectomydue to neoplasm in the Department of Otorhinolaryngology, Head and Neck Surgery of a tertiary referral center from 2012 to 2017 were reviewed. Results: Among 178 patients, twenty-two insert ignore into journalissuearticles values(12.4%); patients were found to underwentprophylactic or therapeutic parotidectomy due to SNP. Six of these patients had pathologically positive parotid metastases insert ignore into journalissuearticles values(therapeutic parotidectomy);. The median age of six patients was 67 years insert ignore into journalissuearticles values(ranging from 2 to 83 years);. Five patients were male and one was female. The most common indication of parotidectomy insert ignore into journalissuearticles values(prophylactic and therapeutic); and pathology of parotid mass due to SNP and Cutaneous Squamous Cell Carcinoma insert ignore into journalissuearticles values(SCC); insert ignore into journalissuearticles values(36.3% and 50%, respectively);. Conclusions: Owing to rapidly progressive feature and high morbidity, close observation of parotid in case of metastasis is crucial for recurrent SCC of the face and scalp. 
Keywords : Head and neck neoplasms, neoplasm metastasis, parotid neoplasms